Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 244.97 billion. The enterprise value is 225.14 billion.
| Market Cap | 244.97B |
| Enterprise Value | 225.14B |
Important Dates
The next estimated earnings date is Friday, February 20, 2026.
| Earnings Date | Feb 20, 2026 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Englewood Lab has 19.87 million shares outstanding.
| Current Share Class | 19.87M |
| Shares Outstanding | 19.87M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.08% |
| Owned by Institutions (%) | 1.45% |
| Float | 6.92M |
Valuation Ratios
The trailing PE ratio is 5.19 and the forward PE ratio is 12.05.
| PE Ratio | 5.19 |
| Forward PE | 12.05 |
| PS Ratio | 1.08 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | 15.51 |
| P/OCF Ratio | 11.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.79, with an EV/FCF ratio of 14.25.
| EV / Earnings | 4.77 |
| EV / Sales | 0.99 |
| EV / EBITDA | 3.79 |
| EV / EBIT | 4.18 |
| EV / FCF | 14.25 |
Financial Position
The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.84 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.44 |
| Debt / FCF | 1.66 |
| Interest Coverage | 46.51 |
Financial Efficiency
Return on equity (ROE) is 33.56% and return on invested capital (ROIC) is 19.93%.
| Return on Equity (ROE) | 33.56% |
| Return on Assets (ROA) | 16.38% |
| Return on Invested Capital (ROIC) | 19.93% |
| Return on Capital Employed (ROCE) | 32.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.10 |
| Inventory Turnover | 3.67 |
Taxes
In the past 12 months, Englewood Lab has paid 9.38 billion in taxes.
| Income Tax | 9.38B |
| Effective Tax Rate | 16.57% |
Stock Price Statistics
The stock price has increased by +66.85% in the last 52 weeks. The beta is 0.48, so Englewood Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +66.85% |
| 50-Day Moving Average | 13,017.00 |
| 200-Day Moving Average | 11,626.35 |
| Relative Strength Index (RSI) | 43.90 |
| Average Volume (20 Days) | 285,881 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 226.73 billion and earned 47.22 billion in profits.
| Revenue | 226.73B |
| Gross Profit | 75.50B |
| Operating Income | 53.92B |
| Pretax Income | 56.60B |
| Net Income | 47.22B |
| EBITDA | 59.47B |
| EBIT | 53.92B |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 39.69 billion in cash and 26.30 billion in debt, giving a net cash position of 13.39 billion or 674.08 per share.
| Cash & Cash Equivalents | 39.69B |
| Total Debt | 26.30B |
| Net Cash | 13.39B |
| Net Cash Per Share | 674.08 |
| Equity (Book Value) | 154.89B |
| Book Value Per Share | 7,572.73 |
| Working Capital | 115.83B |
Cash Flow
In the last 12 months, operating cash flow was 21.92 billion and capital expenditures -6.12 billion, giving a free cash flow of 15.79 billion.
| Operating Cash Flow | 21.92B |
| Capital Expenditures | -6.12B |
| Free Cash Flow | 15.79B |
| FCF Per Share | 794.99 |
Margins
Gross margin is 33.30%, with operating and profit margins of 23.78% and 20.83%.
| Gross Margin | 33.30% |
| Operating Margin | 23.78% |
| Pretax Margin | 24.96% |
| Profit Margin | 20.83% |
| EBITDA Margin | 26.23% |
| EBIT Margin | 23.78% |
| FCF Margin | 6.97% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 0.81%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 0.81% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 4.60% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.79% |
| Earnings Yield | 19.28% |
| FCF Yield | 6.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Englewood Lab has an Altman Z-Score of 4.48 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.48 |
| Piotroski F-Score | 4 |